{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:53:39Z","timestamp":1787072019048,"version":"build-2736575974"},"reference-count":69,"publisher":"American Chemical Society (ACS)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci?n y Universidades","doi-asserted-by":"publisher","award":["PID2024-156686NB-I00"],"award-info":[{"award-number":["PID2024-156686NB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut?noma de Madrid","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008328","name":"Universidad de La Habana","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015650","name":"Fundaci?n Carolina","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100015650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Developing brain-penetrant BACE1 inhibitors remains a major challenge in Alzheimer\u2019s disease. Unlike conventional studies focusing solely on binding affinity, this work presents an integrated computational pipeline that prioritizes both potency and pharmacokinetic developability from the outset. A robust quantitative structure\u2013activity relationship (QSAR) model was built for 41 N-(pyridin-3-yl)picolinamide derivatives using Molecular Electrostatic Surface Potential (MESP) descriptors. Principal component analysis identified three key electrostatic features \u2013 mean MESP, variance of negative MESP, and number of local MESP maxima\/minima as drivers of BACE1 inhibitory activity. A key novelty is the early integration of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) filtering, using ADMETlab 3.0, to ensure blood-brain barrier (BBB) permeability and low P-glycoprotein efflux properties whose absence contributed to the failure of several clinical BACE1 inhibitors. Only compound N-[3-[(1S,5S,6S)-3-amino-1-(difluoromethyl)-5-(fluoromethyl)-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4-fluorophenyl]-5-chloropyrazine-2-carboxamide (5) simultaneously satisfied the criteria for high predicted potency, favorable BBB penetration, low PgP efflux, and good synthetic accessibility. Molecular docking revealed that compound 5 binds strategically to the S1 and S3 substrate-recognition pockets through hydrogen bonds with THR280, GLN121, LYS155, as well as a halogen interaction with ARG283, while avoiding direct interaction with the catalytic dyad. This binding mode balances affinity and permeability, distinguishing compound 5 from clinically unsuccessful inhibitors. The practical implication is a rational framework that rapidly prioritizes candidates with high potency and favorable Central Nervous System (CNS) drug-like properties, thereby reducing the risk of late-stage attrition. All predictions are computational and require experimental validation (enzymatic, cellular, and in vivo) before any translational claims can be made. Thus, combining QSAR, ADMET, and molecular docking with an early emphasis on BBB penetration offers a time-efficient strategy for CNS drug discovery against Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.1021\/acsomega.6c02969","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:01:31Z","timestamp":1786093291000},"page":"47739-47753","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Virtual Screening and Molecular Electrostatic\nSurface Potential Descriptors for Predicting BACE1 Inhibitor Interactions\nin Alzheimer\u2019s Disease"],"prefix":"10.1021","volume":"11","author":[{"given":"Yoanna","family":"Alvarez-Ginarte","sequence":"first","affiliation":[{"name":"Universidad de la Habana , , ,","place":["Havana, Cuba, 10400"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-7534","authenticated-orcid":true,"given":"Rafael","family":"Lo\u0301pez","sequence":"additional","affiliation":[{"name":"Universidad Auto\u0301noma de Madrid , , , ,","place":["Madrid, Madrid, Spain, 28049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1940-422X","authenticated-orcid":true,"given":"Jose\u0301 Manuel","family":"Garci\u0301a de la Vega","sequence":"additional","affiliation":[{"name":"Universidad Auto\u0301noma de Madrid , , , ,","place":["Madrid, Madrid, Spain, 28049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"De Ema","sequence":"additional","affiliation":[{"name":"Universidad Auto\u0301noma de Madrid , , , ,","place":["Madrid, Madrid, Spain, 28049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alpi\u0301zar-Pedraza","sequence":"additional","affiliation":[{"name":"Center for Pharmaceuticals Research and Development (CIDEM) , ,","place":["La Habana, Cuba, 10400"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"4","key":"2026081810495813500_cit1","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1021\/acs.jmedchem.5c02468","article-title":"Alzheimer\u2019s\nDisease: Evolving Therapeutics, Scientific Progress, and Key Challenges","volume":"69","author":"K","year":"2026","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026081810495813500_cit2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug Development\nin Alzheimer\u2019s\nDisease: The Path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"2026081810495813500_cit3","doi-asserted-by":"publisher","first-page":"1453489","DOI":"10.3389\/fpubh.2024.1453489","article-title":"Assessing\nand Projecting the Global\nImpacts of Alzheimer\u2019s Disease","volume":"12","author":"Zhang","year":"2025","journal-title":"Front.\nPublic Health"},{"issue":"10","key":"2026081810495813500_cit4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2174\/0115672050336253241227102506","article-title":"Discovery of Selective \u03b2-Secretase\n(BACE-1) Inhibitors by the Solid-PhaseSynthesis of Small Molecular-Sized\nPeptides","volume":"21","author":"Ullah","year":"2025","journal-title":"Curr. Alzheimer Res."},{"issue":"9","key":"2026081810495813500_cit5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jalz.2019.06.3918","article-title":"Multiple BACE1 Inhibitors Abnormally Increase the BACE1\nProtein Level in Neurons by Prolonging Its Half-life","volume":"15","author":"Liu","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"9","key":"2026081810495813500_cit6","doi-asserted-by":"publisher","first-page":"e2848","DOI":"10.1002\/jmr.2848","article-title":"Understanding the\nDisrupting Mechanism of the Tau Aggregation Motif \u201c 306VQIVYK311 \u201d by Phenylthiazolyl-hydrazides\nInhibitors","volume":"33","author":"Moreno-Castillo","year":"2020","journal-title":"J. Mol. Recognit."},{"issue":"3","key":"2026081810495813500_cit7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1021\/acs.jmedchem.7b00393","article-title":"BACE-1 Inhibitors:\nFrom Recent Single-Target Molecules to Multitarget Compounds for Alzheimer\u2019s\nDisease: Miniperspective","volume":"61","author":"Prati","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026081810495813500_cit8","doi-asserted-by":"publisher","first-page":"e01347","DOI":"10.1002\/adts.202501347","article-title":"A Predictive ML-QSAR Approach for Targeting GSK-3\u03b2\nin Alzheimer\u2019s Disease","volume":"9","author":"Maliyakkal","year":"2026","journal-title":"Adv. Theory Simul."},{"issue":"2","key":"2026081810495813500_cit9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1568026623666221228140450","article-title":"Drug Discovery to\nDrug Development of BACE1 Inhibitor\nas Antialzheimer\u2019s: A Review","volume":"23","author":"Munj","year":"2023","journal-title":"Curr. Top.\nMed. Chem."},{"key":"2026081810495813500_cit10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights\nin BACE1 Inhibitors for Alzheimer\u2019s Disease Treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front. Chem."},{"issue":"9","key":"2026081810495813500_cit11","doi-asserted-by":"publisher","first-page":"104448","DOI":"10.1016\/j.drudis.2025.104448","article-title":"Revolutionizing\nDrug Discovery: Integrating\nArtificial Intelligence with Quantitative Systems Pharmacology","volume":"30","author":"Goryanin","year":"2025","journal-title":"Drug Discovery Today"},{"key":"2026081810495813500_cit12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-443-23841-3.00015-7","article-title":"Artificial Intelligence: Ways and\nMeans for Central Nervous System (CNS) Delivery","volume-title":"Targeted Therapy for the Central Nervous System","author":"Patel","year":"2025"},{"issue":"7","key":"2026081810495813500_cit13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/ph18071041","article-title":"From Molecules\nto Medicines: The Role of AI-Driven Drug Discovery Against Alzheimer\u2019s\nDisease and Other Neurological Disorders","volume":"18","author":"Alghamdi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2026081810495813500_cit14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14283\/jpad.2023.1","article-title":"Accelerating Innovations for Enhanced\nBrain Health. Can Artificial\nIntelligence Advance New Pathways for Drug Discovery for Alzheimer\u2019s\nand Other Neurodegenerative Disorders?","volume":"10","author":"Khachaturian","year":"2023","journal-title":"J. Prev.\nAlzheimers Dis."},{"issue":"3","key":"2026081810495813500_cit15","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s11030-021-10282-8","article-title":"Machine Learning Models for Predicting the Activity\nof AChE and BACE1 Dual Inhibitors for the Treatment of Alzheimer\u2019s\nDisease","volume":"26","author":"Dhamodharan","year":"2022","journal-title":"Mol. Divers."},{"issue":"11","key":"2026081810495813500_cit16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s40273-021-01065-y","article-title":"How Much Does It Cost\nto Research and Develop a New\nDrug? A Systematic Review and Assessment","volume":"39","author":"Schlander","year":"2021","journal-title":"PharmacoEconomics"},{"issue":"2","key":"2026081810495813500_cit17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.55197\/qjmhs.v4i2.153","article-title":"ADVANCES IN DRUG DESIGN: A REVIEW OF RECENT TRENDS,\nCHALLENGES AND FUTURE SCOPE","volume":"4","author":"Singh","year":"2025","journal-title":"Quantum J. Med.\nHealth Sci."},{"issue":"2","key":"2026081810495813500_cit18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/ddc2020017","article-title":"Virtual Screening\nAlgorithms in Drug Discovery: A Review Focused on Machine and Deep\nLearning Methods","volume":"2","author":"Oliveira","year":"2023","journal-title":"Drugs Drug Candidates"},{"issue":"1","key":"2026081810495813500_cit19","doi-asserted-by":"publisher","first-page":"28321","DOI":"10.1038\/s41598-024-79799-w","article-title":"Deep Learning\nPipeline for Accelerating\nVirtual Screening in Drug Discovery","volume":"14","author":"Noor","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"2026081810495813500_cit20","doi-asserted-by":"publisher","first-page":"e1735","DOI":"10.1002\/wcms.1735","article-title":"Unveiling Drug Discovery\nInsights Through Molecular\nElectrostatic Potential Analysis","volume":"14","author":"Haritha","year":"2024","journal-title":"WIREs Comput.\nMol. Sci."},{"issue":"1","key":"2026081810495813500_cit21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41597-023-02443-1","article-title":"A Quantum\nChemical Interaction Energy Dataset for Accurately Modeling Protein-Ligand\nInteractions","volume":"10","author":"Spronk","year":"2023","journal-title":"Sci. Data"},{"issue":"1","key":"2026081810495813500_cit22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s42004-024-01328-7","article-title":"Accurate Protein-Ligand\nBinding Free Energy Estimation\nUsing QM\/MM on Multi-Conformers Predicted from Classical Mining Minima","volume":"7","author":"Molani","year":"2024","journal-title":"Commun. Chem."},{"issue":"9","key":"2026081810495813500_cit23","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1007\/s42250-025-01398-7","article-title":"Design of\nNovel PI3K\u03b1\nInhibitors by Combining 3D-QSAR, ADMET Screening, Molecular Docking,\nand Molecular Dynamics Simulations","volume":"8","author":"Wang","year":"2025","journal-title":"Chem. Afr."},{"issue":"1","key":"2026081810495813500_cit24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41597-023-02443-1","article-title":"A Quantum\nChemical Interaction Energy Dataset for Accurately Modeling Protein-Ligand\nInteractions","volume":"10","author":"Spronk","year":"2023","journal-title":"Sci. Data"},{"issue":"1","key":"2026081810495813500_cit25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s42004-024-01328-7","article-title":"Accurate Protein-Ligand\nBinding Free Energy Estimation\nUsing QM\/MM on Multi-Conformers Predicted from Classical Mining Minima","volume":"7","author":"Molani","year":"2024","journal-title":"Commun. Chem."},{"key":"2026081810495813500_cit26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.molstruc.2019.02.071","article-title":"3D-QSAR and Molecular Docking Studies of Aminopyrimidine\nDerivatives\nas Novel Three-Targeted Lck\/Src\/KDR Inhibitors","volume":"1185","author":"Xie","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"6","key":"2026081810495813500_cit27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bmcl.2018.12.049","article-title":"New\nEvolutions in the BACE1 Inhibitor\nField from 2014 to 2018","volume":"29","author":"Hsiao","year":"2019","journal-title":"Bioorg. Med. Chem.\nLett."},{"issue":"1","key":"2026081810495813500_cit28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13543776.2021.1832463","article-title":"Small-Molecule\nBACE1 Inhibitors: A Patent Literature Review (2011 to 2020)","volume":"31","author":"Rombouts","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"2026081810495813500_cit29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/1062936X.2025.2478123","article-title":"Predictive\nModelling of Peroxisome Proliferator-Activated Receptor Gamma (PPAR\u03b3)\nIC50 Inhibition by Emerging Pollutants Using Light Gradient Boosting\nMachine","volume":"36","author":"Awomuti","year":"2025","journal-title":"SAR QSAR Environ. Res."},{"issue":"14","key":"2026081810495813500_cit30","doi-asserted-by":"publisher","first-page":"144107","DOI":"10.1063\/5.0005081","article-title":"The Molpro Quantum Chemistry Package","volume":"152","author":"Werner","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"7","key":"2026081810495813500_cit31","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-Functional\nThermochemistry. III. The Role of Exact Exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"2","key":"2026081810495813500_cit32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development\nof the Colle-Salvetti\nCorrelation-Energy Formula into a Functional of the Electron Density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"issue":"48","key":"2026081810495813500_cit33","doi-asserted-by":"publisher","first-page":"11232","DOI":"10.1021\/acs.jpca.5c05079","article-title":"Reduced Serially Improved GTOs for\nMolecular Applications from H to Ar: Efficient Diffuse Functions in\nAugmented Basis Sets","volume":"129","author":"Ema","year":"2025","journal-title":"J. Phys. Chem. A"},{"issue":"1","key":"2026081810495813500_cit34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-026-01166-w","article-title":"How Quantum-Chemical Geometry Optimization\nLevel Affects Classical 3D Descriptors and QSAR Performance: A Comparative\nStudy","volume":"18","author":"Li","year":"2026","journal-title":"J. Cheminformatics"},{"key":"2026081810495813500_cit35","doi-asserted-by":"publisher","first-page":"104384","DOI":"10.1016\/j.chemolab.2021.104384","article-title":"Quantum Chemical Descriptors in Quantitative\nStructure-Activity Relationship\nModels and Their Applications","volume":"217","author":"Wang","year":"2021","journal-title":"Chemom. Intell.\nLab. Syst."},{"key":"2026081810495813500_cit36","doi-asserted-by":"publisher","first-page":"108460","DOI":"10.1016\/j.cpc.2022.108460","article-title":"DAMQT 3: Advanced\nSuite for the Analysis of Molecular Density and Related Properties\nin Large Systems","volume":"279","author":"Kumar","year":"2022","journal-title":"Comput. Phys. Commun."},{"issue":"37","key":"2026081810495813500_cit37","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1021\/j100139a019","article-title":"Relationships of Critical\nConstants and Boiling Points\nto Computed Molecular Surface Properties","volume":"97","author":"Murray","year":"1993","journal-title":"J.\nPhys. Chem."},{"issue":"3","key":"2026081810495813500_cit38","doi-asserted-by":"publisher","first-page":"e70014","DOI":"10.1002\/cem.70014","article-title":"Origin of\nthe OECD Principles for QSAR Validation and Their Role in Changing\nthe QSAR Paradigm Worldwide: An Historical Overview","volume":"39","author":"Gramatica","year":"2025","journal-title":"J. Chemom."},{"issue":"1","key":"2026081810495813500_cit39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/ijms25010192","article-title":"Principal Component Analysis (PCA) of Molecular Descriptors\nfor Improving Permeation through the Blood-Brain Barrier of Quercetin\nAnalogues","volume":"25","author":"Pavlovic\u0301","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"2026081810495813500_cit40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1521-3838(200012)19:6&lt;599::AID-QSAR599&gt;3.0.CO;2-B","article-title":"BuildQSAR: A New Computer Program\nfor QSAR Analysis","volume":"19","author":"De Oliveira","year":"2000","journal-title":"Quant. Struct.-Act. Relatsh."},{"issue":"3","key":"2026081810495813500_cit41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10182-007-0038-x","article-title":"StatSoft,\nInc., Tulsa, OK.: STATISTICA, Version 8","volume":"91","author":"Wei\u00df","year":"2007","journal-title":"AStA\nAdv. Stat. Anal."},{"issue":"6","key":"2026081810495813500_cit42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.22937\/IJCSNS.2021.21.6.31","article-title":"Comprehensive Review\non Clustering\nTechniques and Its Application on High Dimensional Data","volume":"21","author":"Alam","year":"2021","journal-title":"Int. J. Comput. Sci. Netw. Secur."},{"issue":"23","key":"2026081810495813500_cit43","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.3390\/molecules26237257","article-title":"CRNNTL: Convolutional\nRecurrent Neural Network and\nTransfer Learning for QSAR Modeling in Organic Drug and Material Discovery","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"2026081810495813500_cit44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/minf.201100101","article-title":"From Molecular Docking\nto 3D-Quantitative\nStructure-Activity Relationships (3D-QSAR): Insights into the Binding\nMode of 5-Lipoxygenase Inhibitors","volume":"31","author":"Eren","year":"2012","journal-title":"Mol. Inform."},{"issue":"4","key":"2026081810495813500_cit45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/1573409914666180426144304","article-title":"Beware of External Validation! - A Comparative Study\nof Several Validation Techniques Used in QSAR Modelling","volume":"14","author":"Majumdar","year":"2018","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"2026081810495813500_cit46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-4939-7899-1_6","article-title":"Applicability\nDomain: A Step\nToward Confident Predictions and Decidability for QSAR Modeling","volume-title":"Computational Toxicology","author":"Kar","year":"2018"},{"issue":"W1","key":"2026081810495813500_cit47","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: An Integrated Online Platform for Accurate\nand Comprehensive Predictions of ADMET Properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"2026081810495813500_cit48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.58920\/sciphar0304264","article-title":"Druggability\nof Pharmaceutical Compounds Using Lipinski Rules with Machine Learning","volume":"3","author":"Nhlapho","year":"2024","journal-title":"Sci. Pharm."},{"issue":"21","key":"2026081810495813500_cit49","doi-asserted-by":"publisher","first-page":"9966","DOI":"10.3390\/app14219966","article-title":"Beyond the Arbitrariness\nof Drug-Likeness Rules: Rough Set Theory and Decision Rules in the\nService of Drug Design","volume":"14","author":"Miebs","year":"2024","journal-title":"Appl. Sci."},{"issue":"11","key":"2026081810495813500_cit50","doi-asserted-by":"publisher","first-page":"e202300115","DOI":"10.1002\/minf.202300115","article-title":"Absorption Matters: A Closer Look at Popular Oral Bioavailability\nRules for Drug Approvals","volume":"42","author":"Caminero Gomes Soares","year":"2023","journal-title":"Mol. Inform."},{"issue":"12","key":"2026081810495813500_cit51","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1021\/acschemneuro.1c00265","article-title":"Comparing the Pfizer\nCentral Nervous System Multiparameter Optimization Calculator and\na BBB Machine Learning Model","volume":"12","author":"Urbina","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"2026081810495813500_cit52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13062-020-00267-2","article-title":"AMDock: A\nVersatile Graphical Tool for Assisting Molecular Docking with Autodock\nVina and Autodock4","volume":"15","author":"Valde\u0301s-Tresanco","year":"2020","journal-title":"Biol. Direct"},{"issue":"2","key":"2026081810495813500_cit53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving\nthe Speed and Accuracy of\nDocking with a New Scoring Function, Efficient Optimization, and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"21","key":"2026081810495813500_cit54","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1021\/jm3008823","article-title":"Structure-Based Design\nof Highly Selective \u03b2-Secretase Inhibitors: Synthesis, Biological\nEvaluation, and Protein-Ligand X-Ray Crystal Structure","volume":"55","author":"Ghosh","year":"2012","journal-title":"J. Med. Chem."},{"issue":"18","key":"2026081810495813500_cit55","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2174\/156802608786786624","article-title":"Medicinal\nChemistry and the Molecular\nOperating Environment (MOE): Application of QSAR and Molecular Docking\nto Drug Discovery","volume":"8","author":"Vilar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"2026081810495813500_cit56","unstructured":"BIOVIA\nDiscovery Studio Visualizer, 2025."},{"issue":"1\u20132","key":"2026081810495813500_cit57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsbmb.2011.04.003","article-title":"Anabolic and Androgenic\nActivities of 19-nor-Testosterone Steroids: QSAR Study Using Quantum\nand Physicochemical Molecular Descriptors","volume":"126","author":"A\u0301lvarez-Ginarte","year":"2011","journal-title":"J.\nSteroid Biochem. Mol. Biol."},{"issue":"18","key":"2026081810495813500_cit58","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.3390\/ijms26189050","article-title":"Simulation and Machine\nLearning Assessment of P-Glycoprotein Pharmacology in the Blood-Brain\nBarrier: Inhibition and Substrate Transport","volume":"26","author":"Jorgensen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026081810495813500_cit59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1208\/s12249-025-03288-0","article-title":"Pharmaceutical Formulations\nand Analytical Methods of Donepezil","volume":"27","author":"Hoang","year":"2026","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"2026081810495813500_cit60","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1039\/C9MD00286C","article-title":"Druggability\nProfile of Stilbene-Derived\nPPAR Agonists: Determination of Physicochemical Properties and PAMPA\nStudy","volume":"10","author":"Linciano","year":"2019","journal-title":"MedChemComm"},{"issue":"1","key":"2026081810495813500_cit61","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijpharm.2016.08.052","article-title":"Comparative\nEvaluation of Rivastigmine Permeation from a Transdermal System in\nthe Franz Cell Using Synthetic Membranes and Pig Ear Skin with in\nVivo-in Vitro Correlation","volume":"512","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"6","key":"2026081810495813500_cit62","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: A Key Regulator\nin Alzheimer\u2019s Disease Progression and CurrentDevelopment of\nIts Inhibitors","volume":"20","author":"Patel","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"2026081810495813500_cit63","doi-asserted-by":"publisher","first-page":"1452558","DOI":"10.3389\/fphys.2024.1452558","article-title":"Preliminary Screening of Biomarkers and Drug Candidates in a Mouse\nModel of \u03b2-Thalassemia Based on Quasi-Targeted Metabolomics","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Physiol."},{"key":"2026081810495813500_cit64","doi-asserted-by":"publisher","first-page":"126501","DOI":"10.1016\/j.ijpharm.2025.126501","article-title":"Advances in Metal Ion-Mediated Macromolecular\nDrug Delivery","volume":"689","author":"Li","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"1","key":"2026081810495813500_cit65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13321-019-0330-2","article-title":"The Nature\nof Ligand Efficiency","volume":"11","author":"Kenny","year":"2019","journal-title":"J. Cheminformatics"},{"issue":"8","key":"2026081810495813500_cit66","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.molcel.2025.03.018","article-title":"Structural Basis and\nBiased Signaling of Proton Sensation by GPCRs Mediated by Extracellular\nHistidine Rearrangement","volume":"85","author":"Guo","year":"2025","journal-title":"Mol. Cell"},{"issue":"20","key":"2026081810495813500_cit67","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1021\/bi200081h","article-title":"Computational Modeling of Substrate\nSpecificity and Catalysis of the \u03b2-Secretase (BACE1) Enzyme","volume":"50","author":"Barman","year":"2011","journal-title":"Biochemistry"},{"issue":"23","key":"2026081810495813500_cit68","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1021\/acs.jmedchem.6b00307","article-title":"Discovery\nof the 3-Imino-1,2,4-Thiadiazinane 1,1-Dioxide Derivative Verubecestat\n(MK-8931)-A \u03b2-Site Amyloid Precursor Protein Cleaving Enzyme\n1 Inhibitor for the Treatment of Alzheimer\u2019s Disease","volume":"59","author":"Scott","year":"2016","journal-title":"J. Med. Chem."},{"issue":"14","key":"2026081810495813500_cit69","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.3390\/ijms26146799","article-title":"LSA-DDI: Learning\nStereochemistry-Aware\nDrug Interactions via 3D Feature Fusion and Contrastive Cross-Attention","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c02969","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/32\/47739\/66456288\/acsomega.6c02969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/32\/47739\/66456288\/acsomega.6c02969.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:14:59Z","timestamp":1787069699000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/32\/47739\/5250128\/Integrated-Virtual-Screening-and-Molecular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":69,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,8,18]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c02969","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}